Selectis Health (GBCS) Equity Average (2011 - 2025)

Selectis Health (GBCS) has 15 years of Equity Average data on file, last reported at -$5.9 million in Q4 2025.

• Quarterly Equity Average fell 15.8% year-over-year to -$5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.9 million (down 15.8% YoY) and the FY2025 annual result came in at -$5.8 million, down 38.77% from the prior year.
• Equity Average advanced to -$5.9 million in Q4 2025 per GBCS's latest filing, from -$6.0 million in the prior quarter.
• The five-year high for Equity Average was $3.9 million in Q2 2023, with the low at -$6.2 million in Q2 2025.
• Average Equity Average over 5 years is -$355456.9, with a median of $1.9 million recorded in 2022.
• Year-over-year, Equity Average jumped 726.74% in 2021 and plunged 347.92% in 2024.
• Selectis Health's Equity Average stood at $3.2 million in 2021, then slumped by 36.41% to $2.1 million in 2022, then sank by 155.37% to -$1.1 million in 2023, then sank by 347.92% to -$5.1 million in 2024, then slipped by 15.8% to -$5.9 million in 2025.
• Business Quant data shows GBCS's Equity Average at -$5.9 million in Q4 2025, -$6.0 million in Q3 2025, and -$6.2 million in Q2 2025.